Drugs / Mivacurium
Mivacurium
also known as
Mivacurium Chloride · BW B109OU · BW B109OU DICHLORIDE · BW-1090U DICHLORIDE · Chlorure de mivacurium · Cloruro de mivacurio · Mivacron · Mivacurium cation · +1 more
Regulatory milestones approvals, filings & regulatory actions · 1 recorded
| Milestone | Jurisdiction | Brand | Indication | Date | Sentence it was read from |
|---|---|---|---|---|---|
| Approved | US (FDA) | MIVACRON | — | 1992-01-22 | fda.gov ↗ |
Trials 4
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 11 trial | ||||||
| Phase 1 | NCT01906528 | Mar → Jul 2013 | — | University of California, San Francisco | Completed | No outcome recorded |
| Phase 21 trial | ||||||
| Phase 2 | NCT02473601 | Oct 2014 → Sep 2015 | liver disorder | Tang-Du Hospital | Unknown | No outcome recorded |
| Phase 41 trial | ||||||
| Phase 4 | NCT02117401 | Jan 2012 → Jun 2013 | — | Jiangsu Nhwa Pharmaceutical Co., Ltd. | Completed | No outcome recorded |
| Phase not applicable1 trial | ||||||
| — | NCT06709066 | Nov 2024 → Dec 2025 overdue | — | Peng Liang | Not yet recruiting | No outcome recorded |
| Comparator or background therapy5 trials | ||||||
| Phase 4 | NCT01631149 Comparator | Jun 2012 → Mar 2013 | benign prostatic hyperplasia, kidney disorder | Leiden University Medical Center | Completed | No outcome recorded |
| Phase 4 | NCT01427985 Comparator | Jun 2011 → Jul 2012 | — | University of Ulm | Completed | No outcome recorded |
| — | NCT06072534 Comparator | Sep 2023 → Jan 2024 | — | Al-Azhar University | Unknown | No outcome recorded |
| — | NCT02664142 Background | Jun 2015 → Sep 2017 | — | University Hospital Ostrava | Completed | No outcome recorded |
| — | NCT01966484 Comparator | Oct 2013 → Jul 2014 | — | Dr. Horst Schmidt Klinik GmbH | Completed | No outcome recorded |
Evidence & citations 13 cited values
Every value below carries the sentence it was read from. 11 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | mivacurium | “Mivacurium is the shortest acting nondepolarizing muscle relaxant currently available” PMID 28415988 ↗ Apr 2017 |
| Known as | BW B109OU | ChEMBL registry synonym — accepted as the source's own label CHEMBL1182833 ↗ |
| Known as | BW B109OU DICHLORIDE | ChEMBL registry synonym — accepted as the source's own label CHEMBL1182833 ↗ |
| Known as | BW-1090U DICHLORIDE | ChEMBL registry synonym — accepted as the source's own label CHEMBL1182833 ↗ |
| Known as | Chlorure de mivacurium | ChEMBL registry synonym — accepted as the source's own label CHEMBL1182833 ↗ |
| Known as | Cloruro de mivacurio | ChEMBL registry synonym — accepted as the source's own label CHEMBL1182833 ↗ |
| Known as | Mivacron | “relaxation: Mivacron (continuous dose of 0.1mg/kg iv.), Tracrium(0.3-0.6 mg/kg)” NCT02664142 ↗ |
| Known as | Mivacurium cation | ChEMBL registry synonym — accepted as the source's own label CHEMBL1182833 ↗ |
| Known as | Mivacurium Chloride | “Drug: "Mivacurium Chloride"” NCT06072534 ↗ |
| Known as | Mivacurium ion | ChEMBL registry synonym — accepted as the source's own label CHEMBL1182833 ↗ |
| Action | Inhibit | “Current anesthesiologic practice during these procedures in the LUMC consists of an intravenous (propofol) or volatile (sevoflurane) anesthetic combined with mivacurium and...” NCT01631149 ↗ |
| Modality | Small molecule | — CHEMBL1182833 ↗ |
| Route | Intravenous | “Constant-rate IV infusions of Mivacurium” NCT01906528 ↗ |